ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

Ich bin auch nicht unzufrieden, aber Geduld wird man trotzdem noch brauchen. So ziehe ich sie nebenbei per Sparplan höher und den Rest macht das Unternehmen 😉

Ich finde das man genug Informationen erhält und es stimmen auch die Zahlen. Ein gutes Unternehmen für die Zukunft

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00517-4/fulltext

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster https://www.prnewswire.com/news-releases/accuray-partners-with-swiss-based-genolier-innovation-hub-to-bring-medical-and-technological-advances-to-patients-faster-301618994.html

Na sie lebt noch

Accuray rises 5% following fiscal 2022 Q4 beats, fY 2023 revenue range within consensus https://seekingalpha.com/news/3871144-accuray-rises-5-following-fiscal-2022-q4-beats-fy-2023-revenue-range-within-consensus • Accuray Inc. (NASDAQ:ARAY) is up 5% in after-hours trading after reporting fiscal 2022 Q4 results that beat on the top and bottom lines and issuing a FY 2023 revenue estimate that falls within analyst consensus. • The company projects FY 2023 revenue of $447M-$455M. The consensus estimate is $451.29M • Adjusted EBITDA is expected in the range of $26 million to $30 million. • Net loss of ~3.5M in the quarter was ~69% narrower compared to FQ4 2021. • Revenue of $110.M was a ~1% year-over-year increase. • Accuray ended the quarter with $88.7M in cash and cash equivalents, a 24% decline from the end of FQ4 2021.

Accuray GAAP EPS of -$0.04 beats by $0.03, revenue of $110.02M beats by $4.7M https://seekingalpha.com/news/3870996-accuray-gaap-eps-of-0_04-beats-0_03-revenue-of-110_02m-beats-4_7m

Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fourth-quarter-and-fiscal-2022-financial-results-301603116.html 8.5% FY22 revenue growth; Company issues guidance for FY23

https://www.surgicalroboticstechnology.com/news/new-clinical-studies-show-benefits-of-accuray-cyberknife-in-treatment-of-neurological-indications/

Sau 👍

Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological https://www.prnewswire.com/news-releases/accuray-cyberknife-system-real-world-data-and-clinical-studies-show-benefits-in-treatment-of-neurological-indications-301583528.html

https://www.benzinga.com/quote/ARAY/analyst-ratings Accuray Price Target Announced at $7.50/Share by B. Riley Securities

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions https://www.prnewswire.com/news-releases/accuray-and-limbus-ai-inc-partner-to-leverage-limbus-innovative-ai-driven-technology-to-enhance-accuray-adaptive-radiotherapy-solutions-301559886.html Partnership will Enable Accuray to Use Limbus' Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency

New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities https://www.prnewswire.com/news-releases/new-data-presented-at-estro-2022-reinforce-benefits-of-accuray-cyberknife-and-tomotherapy-platforms-across-a-range-of-indications-and-complexities-301543379.html More Than 70 Abstracts Build on the Clinical Evidence Supporting the Use of These Technologies

Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award https://www.prnewswire.com/news-releases/accuray-clearrt-helical-fan-beam-kvct-imaging-wins-best-new-technology-solution-for-oncology-medtech-breakthrough-award-301540539.html Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

https://investors.accuray.com/news-releases/news-release-details/accuray-announces-suzanne-winter-president-promoted-president